![](/img/cover-not-exists.png)
Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: a phase II study of the Spanish GOTI group
Garcia-Alfonso, P, Muñoz-Martin, A, Mendez-Ureña, M, Quiben-Pereira, R, Gonzalez-Flores, E, Perez-Manga, GVolume:
101
Year:
2009
Language:
english
Pages:
5
DOI:
10.1038/sj.bjc.6605261
File:
PDF, 108 KB
english, 2009